Your browser doesn't support javascript.
loading
Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment.
Tazzari, Marcella; Indio, Valentina; Vergani, Barbara; De Cecco, Loris; Rini, Francesca; Negri, Tiziana; Camisaschi, Chiara; Fiore, Marco; Stacchiotti, Silvia; Dagrada, G Paolo; Casali, Paolo G; Gronchi, Alessandro; Astolfi, Annalisa; Pantaleo, Maria A; Villa, Antonello; Lombardo, Claudia; Arienti, Flavio; Pilotti, Silvana; Rivoltini, Licia; Castelli, Chiara.
Afiliación
  • Tazzari M; Unit of Immunotherapy of Human Tumors, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Indio V; Giorgio Prodi Cancer Research Center, University of Bologna, Bologna, Italy.
  • Vergani B; Consorzio MIA (Microscopy and Image Analysis), University of Milano-Bicocca, Milan, Italy.
  • De Cecco L; Functional Genomics Core Facility, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Rini F; Unit of Immunotherapy of Human Tumors, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Negri T; Laboratory of Experimental Molecular Pathology, Department of Diagnostic Pathology and Laboratory, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Camisaschi C; Unit of Immunotherapy of Human Tumors, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Fiore M; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Stacchiotti S; Adult Sarcoma Medical Oncology Unit, Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Dagrada GP; Laboratory of Experimental Molecular Pathology, Department of Diagnostic Pathology and Laboratory, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Casali PG; Adult Sarcoma Medical Oncology Unit, Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Gronchi A; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Astolfi A; Giorgio Prodi Cancer Research Center, University of Bologna, Bologna, Italy.
  • Pantaleo MA; Giorgio Prodi Cancer Research Center, University of Bologna, Bologna, Italy; Department of Specialized, Experimental and Diagnostic Medicine, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
  • Villa A; Consorzio MIA (Microscopy and Image Analysis), University of Milano-Bicocca, Milan, Italy.
  • Lombardo C; Service of Immunohematology & Transfusion Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Arienti F; Service of Immunohematology & Transfusion Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Pilotti S; Laboratory of Experimental Molecular Pathology, Department of Diagnostic Pathology and Laboratory, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Rivoltini L; Unit of Immunotherapy of Human Tumors, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Castelli C; Unit of Immunotherapy of Human Tumors, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: chiara.castelli@istitutotumori.mi.it.
J Invest Dermatol ; 137(2): 484-493, 2017 02.
Article en En | MEDLINE | ID: mdl-27608549
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Dermatofibrosarcoma / Inmunidad Adaptativa / Mesilato de Imatinib / Antineoplásicos Límite: Humans Idioma: En Revista: J Invest Dermatol Año: 2017 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Dermatofibrosarcoma / Inmunidad Adaptativa / Mesilato de Imatinib / Antineoplásicos Límite: Humans Idioma: En Revista: J Invest Dermatol Año: 2017 Tipo del documento: Article País de afiliación: Italia